1Cozzolino M,Pasho S,Fallabrino G. Pathogenesis of secondary hyperparathyroidism[J].International Journal of Artificial Organs,2009.3275-3280.
2Brown EM. Clinical lessons from the calcium-sensing receptor[J].Endocrinology and Metabolism,2007.122-133.
3Matsuo K,Irie N. Osteoclast-osteoblast communication[J].Archives of Biochemistry and Biophysics,2008,(473):201-209.
4Hoenderop JG,Nilius B,Bindels RJ. Calcium absorption across epithelia[J].Physiological Reviews,2005.373-422.
5Padhi D,Harris RZ,Salfi M. No effect of renal function or dialysis on pharmacokinetics of cinacalcet (Sensipar/Mimpara)[J].Clinical Pharmacokinetics,2005.509-516.
6Colloton M,Shatzen E,Miller G. Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism[J].Kidney International,2005.467-476.
7Mendoza FJ,Lopez I,Canalejo R. s Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats[J].American Journal of Physiology-Renal Physiology,2009.F605-F613.
8Francisco AL,Izquierdo M,Cunningham J. Calciummediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet[J].Nephrology Dialysis Transplantation,2008.2895-2901.
9Nemeth EF,Heaton WH,Miller M. Pharmacodynamics of the type Ⅱ calcimimetic compound cinacalcet HCl[J].Journal of Pharmacology and Experimental Therapeutics,2004.627-635.
10Rodriguez ME,Almaden Y,Candillas S. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands[J].American Journal of Physiology-Renal Physiology,2007.F1390-F2195.
